NCT01090037View on ClinicalTrials.gov

TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

892

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

August 31, 2014

Study Completion Date

January 31, 2015

Conditions
Chronic Renal FailureGlomerular DiseaseNephrosclerosis
Interventions
DRUG

TRK-100STP high dose

DRUG

TRK-100STP low dose

DRUG

Placebo

Trial Locations (7)

Unknown

Beijing

Hong Kong

Tokyo

Kuala Lumpur

Seoul

Taipei

Bangkok

Sponsors

Collaborators (1)

Astellas Pharma Inc
All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Toray Industries, Inc

INDUSTRY